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AHNAK, a large size-phosphoprotein, plays a crucial role in the cell 
adhesion, proliferation and calcium signaling. Recently emerging evidence 
has suggested that AHNAK expression is altered in obese condition. 
Nevertheless, the role of AHNAK during adipose tissue development 
remains unclear. The objective of this study was to determine the molecular 
mechanism of AHNAK in adipogenesis and glucose homeostasis. In this 
study, AHNAK KO mice displayed resistance to diet-induced obesity due to 
reduction of fat accumulation. We found that adipogenesis from adipose 
derived mesenchymal stem cells (ADSCs) was severely impaired in AHNAK 
KO mice, which could contribute to whole-body fat accumulation. We also 
observed that loss of AHANK led to a decreased BMP4/SMAD1 signaling, 
resulting in decreased expression of key regulators for adipocyte 
differentiation. AHNAK directly interacts with Smad1 on the PPAR2 
transcription activity. Concomitantly, AHNAK KO mice displayed a better 
degree of metabolic profiles, including improved glucose tolerance, 
enhanced insulin sensitivity, and higher energy expenditure without 
alteration in food intake and physical activity. Taken together, Ahnak plays 
a crucial role in body fat accumulation by regulation of adipose tissue 
development through interaction with Smad1 protein and can be involved in 
metabolic homeostasis. 
 Changes in brown adipose tissue (BAT) activity and energy 
expenditure through thermogenesis would be a promising therapeutic target 
against obesity. In adipose tissue, agonists of the3-adrenergic receptor 
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(ADRB3) regulate lipolysis, lipid oxidation, and thermogenesis. AHNAK 
deficiency induced thermogenesis in white adipose tissue (WAT) of mice fed 
high-fat diet, suggesting that AHNAK may stimulate energy expenditure via 
the development of beige fat. Here, we report that AHNAK deficiency 
promoted browning and thermogenic gene expression in WAT but not in 
brown adipose tissue of mice stimulated with the ADRB3 agonist CL-
316243. Consistent with increased thermogenesis, AHNAK KO mice 
exhibited an increase in energy expenditure, accompanied by elevated 
mitochondrial biogenesis in WAT depots in response to CL-316243. CL-
316243 activated PKA signaling and enhanced lipolysis, as evidenced by 
increased phosphorylation of hormone sensitive lipase and release of free 
glycerol in AHNAK KO mice compared to the wild-type mice. AHNAK 
deficient WAT contains more eosinophil and type 2 cytokines (IL-4/IL-13) 
to promote browning of WAT and mitochondrial biogenesis in response to 
CL. This is associated with enhanced sympathetic tone in WAT via 
upregulation of adrb3 and tyrosine hydroxylase (TH) expression in AHNAK 
KO mice in response to-adrenergic activation. Overall, these findings 
suggest an important role of AHNAK in the regulation of thermogenesis and 
lipolysis in WAT via  -adrenergic signaling. 
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 AHNAK, located on human chromosome 11q 12-13, is a giant 
protein of approximately 700kD in size initially identified in human 
neuroblastomas and skin epithelial cells (Hashimoto et al., 1995; Shtivelman 
and Bishop, 1993; Shtivelman et al., 1992). In epithelial cells, AHANK is 
mainly localized in the nucleus in low calcium concentrations, but an 
increase in intracellular calcium levels leads to translocation of the protein 
to the plasma membrane (Nie et al., 2000). AHNAK, as a scaffolding 
protein, plays an important role in the formation of cytoskeletal structure, 
calcium homeostasis, and muscle regeneration (Alvarez et al., 2004; Hohaus 
et al., 2002; Huang et al., 2007). The protein structure of AHNAK contains 
three main parts (Figure 1-1): N-terminal, central, and C-terminal domain. 
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PDZ-containing N-terminal domain has 251 amino acids and the carboxyl-
terminal includes 1002 amino acid residues which are involved in skeletal 
muscle regeneration and calcium signaling (Davis et al., 2014; Hohaus et al., 
2002). The central domain with 36 central repeated units (CRU) activates 
phospholipase C-γ1 (PLC γ 1) as well as protein kinase C-α (PKC-α) (Lee et 
al., 2008; Lee et al., 2004). Moreover, AHANK is involved in plasma 
membrane differentiation and repair by calcium-induced exocytosis called 
enlargosome, and functions in brain endothelial cells in maintenance of the 
integrity of the blood brain barrier (Borgonovo et al., 2002; Gentil et al., 
2005).  
 It had been assumed that deficiency of AHNAK would lead to 
significant phenotypes since it is implicated in multiple organs. Nevertheless, 
AHNAK deficiency displayed no overt phenotypes in muscle cells and 
epidermis of null mutation mice (Komuro et al., 2004; Kouno et al., 2004) A 
previous study using AHNAK knockout mice has shown that AHANK is 
required for the activation and proliferation of T cells and calcium influx in 
CD4+ T cells (Matza et al., 2008). Recent studies suggested that AHNAK 
plays a crucial role in not only the cell cycle to stimulate the activation of c-
raf, MEK, and Erk signaling in mouse embryonic fibroblast cells (MEF), 
but also the activation of Erk and Rac in PDGF-dependent migration of 
mouse aortic smooth muscle cells (ASMC) (Lee et al., 2008; Lim et al., 
2013). Furthermore, it has also been suggested that AHNAK is a tumor 
suppressor as an important component of TGFβ/Smad signaling pathway 
(Lee et al., 2014). 
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Figure 1-2. Bone Morphogenetic Protein Pathway. (Hyun et al. INTECH Open 




 White adipose tissue (WAT) is important for maintaining energy 
balance, storing calories in the form of lipids, and supplying energy sources 
in response to hormonal stimulation(Rosen and Spiegelman, 2006). We first 
reported that AHNAK KO mice are protected from diet-induced obesity due 
to alteration of metabolomic profiles in urine and blood between high fat-
fed wild-type and AHNAK KO mice (Kim et al., 2010). This finding was 
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reconfirmed by Ramdas et al. (Ramdas et al., 2015). In addition, Li et al. 
showed upregulation of AHNAK in the adipose tissue of diet-induced 
obesity rat models (Li et al., 2002). However, the molecular mechanism of 
AHNAK during adipogenesis remains unclear. 
 Bone morphogenetic proteins (BMPs) are important regulators of 
proliferation, apoptosis and differentiation during various developmental 
processes (Chen et al., 2004; Margoni et al., 2012). Several evidences have 
suggested that BMP signaling promote cell fate determination in the 
mammalian systems (Kang et al., 2008; Schulz and Tseng, 2009; Zhao, 
2003). The effects of BMP2 and -4 in the mesenchymal stem cell line 
C3H10T1/2 induce commitment to preadipocyte and promote adipogenic 
differentiation (Huang et al., 2009; Tang et al., 2004; Wang et al., 1993). 
BMP signal trasnduction stimulates phophorylation of Smad1/5/8. The 
heterodimeric complex Smad1/5/8 and Smad4 translocates the nucleus and 
modulate the transcriptional activity of C/EBP family and PPARγ (Figure 1-
2) (Huang et al., 2009; Rosen and MacDougald, 2006; Zamani and Brown, 
2011). 
 It was proposed that AHNAK regulates cell growth by mediating 
TGF/Smad signaling (Lee et al., 2014). Studies have shown that bone 
morphogenetic proteins (BMPs), members of the transforming growth factor 
 (TGF) are involved in adipocyte differentiation and Smad family plays 
important roles in BMP/TGF signaling (Huang et al., 2009; Rosen and 
MacDougald, 2006; Zamani and Brown, 2011). The present study aimed to 
elucidate the molecular mechanism leading to impaired adipogenesis in 
Ahnak KO which have been subjected to enhanced metabolic features. 
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Furthermore, we demonstrate the critical role of Ahnak in adipogenesis via 




` - 7 -
 
1.2. Materials and Methods 
 
Animals 
Ahnak knockout mice were generated by disruption of exon 5 in the Ahnak 
gene, as previously described (Lee et al., 2008). AHNAK-KO (Ahnak-/-) 
mice were obtained by crossing heterozygous breeders. 6-week-old male 
KO and wild-type mice were fed either a regular chow (RC) diet or a high 
fat diet (HFD; 20% carbohydrate, 60% fat, 20% protein; D12492; Research 
Diets Inc., New Brunswick, NJ, USA). Mice were maintained under a 12-h 
light-dark cycle and had free access to water in a specific pathogen-free 
barrier facility. Mice were randomly assigned. These procedures were 
approved by the Institutional Animal Care and Use Committee of Seoul 
National University (Permit Number: SNU-201004-14) in accordance with 
the Principles of Laboratory Animal Care (NIH publication no. 85–23, 
revised 1985).  
 
Cell culture, reagents, and plasmids  
Murine 3T3-L1 and C3H10T1/2 cells were kindly provided as a gift by Dr. 
Jae Woo Kim (Yonsei University, Seoul, South Korea)(Bowers et al., 2006; 
Lee et al., 2012a). Cells were differentiated into mature adipocytes as 
described (Bowers et al., 2006), with modifications. Flag-Ahnak (N-terminal, 
amino-acid residues 1-150) and HA-Smad1(Liu et al., 1996) expression 
vectors were purchased from GeneCopoeia (Rockville, MD, USA) and 
Addgene, respectively. C3H10T1/2 cells were transfected directly with total 
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of 4㎍ plasmid DNA using Lipofectamine LTX with Plus reagent 
(Invitrogen, Carlsbad, CA, USA) according to the manufacturer's protocol. 
FlexiTube small interfering RNA (siRNA) directed against murine Ahnak 
mRNA (accession no. NM_001039959) was from Qiagen. siRNA 
transfections were performed with Lipofectamine RNAiMAX (Invitrogen), 
according to the manufacturer’s protocol. AllStars Negative Control siRNA 
was obtained from Qiagen (Hilden, Germany). 
 
Isolation and expansion of adipose-derived stem cells (ADSCs)  
The establishment of wild-type (WT) and AHNAK-KO ADSCs isolated 
from epididymal and inguinal WATs of 8–10-week-old mice was described 
previously (Rajkumar et al., 1999; Yamamoto et al., 2007). Briefly, adipose 
tissue was minced and digested with 0.75 mg/ml collagenase (Wako Pure 
Chemical Industries, Ltd., Osaka, Japan) for 2 h at 37°C. Cells were added 
to RBC lysis buffer (eBioscience, San Diego, CA) and filtered through a 
100-m cell strainer (BD Falcon, Franklin Lakes, NJ, USA) to generate 
single-cell suspensions. Cells were diluted to 1 × 105 cells/cm2 in 
DMEM/F12 medium (Gibco, pH 7.4) containing 10% FBS and maintained 
in 5% CO2 at 37°C.  
 
Immunostaining 
ADSCs were grown on chamber slides and exposed to BMP4 for 1 hour. 
Cells were fixed and then permeabilized in 0.25% Triton-X 100 at room 
temperature for 10 min. After washing with PBS, the cells were blocked 
with 10% normal goat serum. For nuclear staining, the samples were 
coverslipped in mounting medium with DAPI (Immunobioscience). Images 
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were captured using a confocal microscope system (LSM 710, Carl Zeiss). 
 
In situ proximity ligation assays  
The interactions between AHANK and SMAD1 were determined by 
performing DuolinkTM in situ proximity ligation assays (PLAs; Sigma), 
according to the manufacturer's instructions. HEK293 and C3H10T1/2 cells 
were stimulated with BMP4 (25 ng/ml) or not stimulated and then fixed, 
permeabilized, and incubated with a mouse anti-AHNAK monoclonal 
antibody in combination with a polyclonal rabbit anti-SMAD1 antibody, 
followed by incubation with secondary antibodies conjugated to PLA probes. 
 
Cellular viability assay 
The cell viability was examined by using an EZ-Cytox Cell viability assay 
kit (Daeil Lab Service, Seoul, Korea). The relative cell viability was 
determined by measuring the absorbance at 450 nm using a Tecan 
microplate reader. 
 
Immunoblotting and immunoprecipitation experiments 
For immunoblot analysis, cells were lysed in PRO-PREP buffer (iNtRON 
Biotechnology Inc., Seoul, Korea) containing a phosphatase-inhibitor 
cocktail (GenDEPOT, Barker, TX, USA). Protein extracts were separated by 
sodium dodecyl sulfate-polyacrylamide gel electrophoresis, transferred to a 
polyvinylidene fluoride membrane (Millipore, Billerica, Massachusetts, 
USA), and subjected to immunoblot analysis. Cytosolic and nuclear 
fractions used in immunoblot analysis were prepared using the NE-PER 
Nuclear and Cytoplasmic Extraction Kit (Thermo Scientific, Rockford, IL, 
USA), according to the manufacturer's instructions. For 
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immunoprecipitation experiments, lysates were immunoprecipitated with an 
anti-HA antibody at 4ºC overnight. Immunocomplexes were washed three 
times with lysis buffer (1% Triton X-100, 20 mM HEPES at pH 7.5, 150 
mM NaCl, 12.5 mM, 10% glycerol, 5 mM EDTA, proteinase inhibitor 
cocktail (GenDEPOT), and a phosphatase inhibitor), mixed with 2X sample 
buffer, and separated from the protein A/G agarose beads (Santa Cruz) by 
boiling. Immunoblot analysis was performed using the indicated antibodies. 
Proteins were visualized by ECL chemiluminescence (AbClon, Seoul, 
Korea). GAPDH was detected as a loading control. Immunoreactive signals 
were detected through their enhanced chemiluminescence and recorded 




The primary antibodies used for western blot analysis were specific for: 
pSMAD1/5, SMAD1, SMAD4, PPARγ, LAMIN B1, GAPDH (Cell 
Signaling Technologies), C/EBPβ, AHNAK (Abcam, Cambridge, UK), and 
GAPDH (all from Cell Signaling Technology, Beverly, MA, USA). The 
antibodies used for immunoprecipitation experiments were AHNAK 
(Abcam) and SMAD1 (Cell Signaling). A peroxidase-conjugated secondary 
antibody (Abclon) was also used. Anti-SMAD1/5 (Abcam) and anti-
pSmad1/5 (Millipore) antibodies were used for immunostaining. Following 
secondary antibodies were used: Alexa Fluor 488- or 594-conjugated 
antibody. DAPI (ImmunoBioScience Co., Washington, USA) was used for 
nuclear staining. 
 
Metabolic assays  
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For glucose-tolerance tests (GTTs), mice were fasted for 16 h and injected 
intraperitoneally with 1.5 mg of glucose/g of body weight. For insulin-
tolerance tests (ITTs), mice were fasted for 6 h and injected intraperitoneally 
with insulin (Humulin R; Eli Lilly, Indianapolis, IN) at 1 unit/kg of body 
weight.  
 
Basal study  
A comprehensive animal metabolic monitoring system (CLAMS; Columbus 
Instruments, Columbus, OH) was used to evaluate activity, food 
consumption, and energy expenditure before and after HFD feeding. Energy 
expenditure and food intake data were normalized with respect to lean body 
weight. Energy expenditure and RQ were calculated from the gas exchange 
data.  
 
Body composition  
Fat and lean body masses were assessed by 1H magnetic resonance 
spectroscopy (Bruker BioSpin, Billerica, MA) before and after mice were 
subjected to an HFD. 
 
Quantitative PCR (qPCR) analysis  
Total RNA was extracted using a total RNA purification system (Invitrogen) 
following to the manufacturer’s protocol. Extracted mRNA was reverse- 
transcribed using AccuPower® CycleScript RT PreMix (Bioneer). 
Quantitative PCR was performed with SYBR Green dye using the ABI Step 
One Real Time PCR instrument (Applied Biosystems, Cheshire, U.K.). For 
relative quantification of gene expression, we used the comparative Ct 
method (ΔΔCt). Results were normalized to the control gene (36B4). The 
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specific primers sequences used for PCR are listed in Supplementary Table 
1. 
 
Biochemical assay  
Serum epinephrine was determined using a commercially available ELISA 
kit according to the manufacturer’s instructions (Abnova, Taipei, Taiwan). 
Serum triglyceride, total cholesterol, HDL-cholesterol and LDL-cholesterol 
concentrations were analyzed by Cobas c111 (Roche). Adipokines, 
including adiponectin, leptin, IL-6, MCP1, PAI-1, and TNF-α were 
measured using MILLIPLEX™ MAP kits (Merck Millipore, Germany) 
according to the manufacturer’s instructions.  
 
Oil red O staining  
Oil red O staining was performed on day 8 following adipogenesis induction. 
Cells were washed and fixed with 4% paraformaldehyde. The cells were 
then washed with 60% isopropanol, dried completely, and stained with oil 
red O (6 parts of 0.5% oil red O powder in isopropanol and 4 parts water) 
for 10 min and washed with phosphate-buffered saline.  
 
GEO search for AHNAK expression  
We used the GEO (Gene Expression Omnibus) database to assess AHNAK 
expression differences in obesity. In this study, we used only GEO dataset 
(GDS)- samples that were already curated. Those datasets contained 
normalized expression values for each gene from each sample. Total 30 
GDS samples were searched in GEO. The differential expression of the 
Ahnak gene was identified by t-test method and a P value < 0.05. 
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Statistics  
All values were expressed as the mean± SEM. Statistical analysis was 
performed using the Student’s t-test between two groups. P<0.05 was 
considered significantly. 
 




1.3.1. Requirement of AHNAK for adipocyte differentiation 
in vitro  
  
 To study the potential correlation between AHNAK expression and 
obesity in humans, we analyzed existing GEO data. AHNAK expression 
was significantly increased in both subcutaneous mature adipocytes (GDS 
1495, P<0.01) and omental adipose tissues (GDS 3688, P<0.05) from obese 
subjects (Figure 1-3A). The AHNAK mRNA levels in normal (B6) and obese 
(Ob/Ob) mice markedly increased in the SVF of WAT, which contains 
multipotent mesenchymal stem cells (Figure 1-3B). AHNAK expression 
was also decreased during adipocyte differentiation in 3T3-L1 cells (Figure 
1-3C), where fully differentiated cells contained mainly adipocytes. 
C3H10T1/2 cells transfected with AHNAK-specific siRNA, were stained 
with oil red O to examine lipid accumulation (Figure 1-4A,B). We found 
that the expression of C/ebp family members Ppar2, aP2, and adiponectin 
significantly decreased during adipogenesis following AHNAK silencing, 
relative to that observed in control-siRNA transfectants (Figure 1-4C). 
Consistently, ADSCs from KO mice showed significantly inhibited 
formation of lipid-containing adipocytes (Figure 1-4D). The adipogenic 
markers were significantly suppressed in AHNAK deficient ADSCs (Figure 
1-4E). Formation of lipid-laden droplets was apparently reduced in fully 
differentiated 3T3-L1 cells by transfection with AHANK-specific siRNA 
(Figure 1-4F). Thus, AHNAK expression in the SVF in WAT may explain 
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the low efficiency of mature adipocyte differentiation observed in AHNAK-
deficient mesenchymal stem cells and the reduced adiposity of AHNAK KO 
mice. 
 





Figure 1-3. AHANK expression in adipose tissue.  
(A) AHNAK expression of obese human subjects. (B) mRNA expression of 
AHNAK in the adipocyte fraction (Ad) and stromal vascular fraction (SVF) of 
eWATs (n=4). (C) mRNA expression of AHANK during adipogenesis in 3T3-L1 
cells. The data shown are means±SEM, *P<0.05, **P<0.01, ***P<0.001 between 
WT and KO mice.  
B C
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Figure 1-4. AHNAK plays a role in adipogenesis in vitro.  
(A) C3H10T1/2 cells were transfected with control siRNA and AHANK siRNA. (B) 
C3H10T1/2 cells underwent adipocyte differentiation, as determined by oil red O 
staining. (C) Expression levels of adipogenic genes were measured by qPCR. All 
genes were normalized to 36B4. (D) Representative pictures showing differentiated 
ADSCs stained with oil red O at day 8 after the induction of differentiation. (E) 
Immunoblot analysis of adipogenic proteins from differentiated cells. GAPDH was 
used as a loading control. (F) 3T3-L1 cells were transfected with siRNA before 
differentiation induction and subsequently stained with oil red O. 
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1.3.2. AHNAK is required for SMAD1/5 activation, which is 
essential for BMP4-dependent adipogenic differentiation  
 
 BMP signaling induces the commitment of mesenchymal stem cells 
into preadipocytes (Huang et al., 2009; Tang et al., 2004). SMAD1/5/8 
phosphorylation is critical for BMP4-mediated transcriptional regulation 
and subsequent commitment to adipocyte differentiation. Thus, we 
examined whether AHNAK is required for BMP4 signaling. Control 
C3H10T1/2 cells and ADSCs treated with recombinant BMP4 showed 
increased SMAD1/5 phosphorylation in a time-dependent manner (Figure 1-
5A,B). However, in AHNAK-deficient C3H10T1/2 cells and ADSCs, 
BMP4-induced SMAD1/5 phosphorylation was repressed (Figure 1-5A,B). 
Importantly, nuclear pSMAD1/5 translocation occurred following BMP4 
treatment in WT ADSCs, but not in KO ADSCs (Figure 1-5C,D). AHNAK 
protein is also translocated into nucleus following BMP4 stimulation 
(Figure 1-5E).  In addition, the expression of SMAD4, a co-SMAD that 
binds to R-SMADs such as SMAD1/5/8 to form an active SMAD complex, 
was suppressed in AHNAK-KO ADSCs after BMP4 treatment, compared to 
that in WT ADSCs. The early adipogenic transcription factor C/EBPβ 
showed a similar trend in terms of expression (Figure 1-5C). Our data 
suggested that the AHNAK protein potentiates BMP4 signaling by 
interacting with SMAD1. To study this potential interaction, Flag-Ahnak and 
HA-Smad1 expression vectors were co-transfected into C3H10T1/2 cells 
and subjected to co-immunoprecipitation with an anti-HA antibody. The 
transfection of Flag-Ahnak expressed vector had no effect on cell viability 
(Figure 1-6A). These results indicated that AHNAK interacted with SMAD1 
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in a BMP4-independent manner (Figure 1-6B). Moreover, a proximity 
ligation assay (PLA) using AHNAK and SMAD1 probes showed that 
AHNAK-SMAD1 complexes were detected as fluorescent spots, both in 
BMP4-treated and vehicle-control cells (Figure 1-6C). BMP2/4-SMAD 
signaling induced adipogenic commitment, which regulates PPAR 
expression (Hata et al., 2003; Huang et al., 2009). We thus evaluated the 
effects of AHNAK on SMAD1-dependent Ppar2 transcriptional regulation 
using a chromatin immunoprecipitation (ChIP) assay. The ChIP complex 
detected with an anti-SMAD1 antibody revealed significantly increased 
association with the Smad-binding element (SBE) in the Ppar2 promoter 
following BMP4 treatment in control siRNA-transfectants. However, 
Ahnak-downregulated cells did not exhibit a SMAD1-bound Ppar2 
promoter DNA fragment (Figure 1-6D). These results indicate that AHNAK 
is required for SMAD1 activation and SMAD1 binding to the Ppar2 
promoter. 





Figure 1-5. AHNAK is required for SMAD1/5 activation, which is essential for 
adipogenic effects caused by BMP4 signaling. (A, B) Following BMP4 
stimulation of C3H10T1/2 cells (A) and ADSCs (B) for the indicated times, the 
levels of indicated proteins were measured by immunoblotting. (C) Following 
BMP4 treatment for 1h, cell lysates from ADSCs were subjected to nuclear and 
cytoplasmic fractionation. Proteins from each fraction were studied by immunoblot 
E 
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analysis. LAMIN B1 and GAPDH were used as nuclear and cytoplasmic markers, 
respectively. (D) Immunofluorescence staining showing the subcellular 
localizations of SMAD1/5 in ADSCs. DAPI was used for nuclear staining. (E) The 
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Figure 1-6. Effects of AHNAK on SMAD1-dependent Ppar2 transcriptional 
regulation.  
(A) Cell viability following transfection of Flag AHANK expressed vector in 
C3H10T cells.  *P<0.05, **P<0.01, ***P<0.001 vs Mock.(B) C3H10T1/2 
cells were transfected with plasmids expressing Flag-AHNAK and HA-SMAD1, 
after which the cells were incubated without or with BMP4 for 60 min. (C) 
Interaction between AHANK and SMAD1. The AHNAK-SMAD1 complexes were 
detected as spots in situ Duolink PLA. (D) DNA-protein complexes from 
C3H10T1/2 cells were immunoprecipitated with an anti-SMAD1 antibody or a 
control IgG. Enrichment of the DNA fragment containing SMAD-binding sites on 
the Ppar2 promoter was evaluated by qPCR. The data shown are the mean 
values ± SEM, *P<0.05, **P<0.01, ***P<0.001 vs Mock.
A B
C D
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1.3.3. AHNAK ablation attenuates adiposity in mice  
 
The tissue distribution of Ahnak was examined in C57BL/6 mice by qPCR 
analysis. AHNAK mRNA was abundantly expressed in white adipose tissue 
(WAT), brown adipose tissue (BAT), heart, and lung tissue (Figure 1-7A). 
To determine the expression of AHNAK in different fat depots, multiple 
adipose tissues were classified as visceral (vis), subcutaneous (subQ) and 
brown fat (BAT). Notably, AHNAK was significantly increased in two 
visceral fat (epididymal, and mesenteric) compared to subQ and BAT 
(inguinal and axillary) (Figure 1-7B). AHNAK gene expression was 
significantly elevated in BAT, epididymal (eWAT) and inguinal (iWAT) fat 
depot in a high fat diet (HFD) fed mice compared to mice fed a regular 
chow (RC) diet (Figure 1-7C). To elucidate the physiological role of 
AHNAK in vivo, we maintained Ahnak-/- (KO), Ahnak+/- (hetero) mice, and 
WT littermates. No differences in body weights were observed between WT 
and hetero mice (Figure 1-7D). However, at 18 weeks of age, Ahnak KO 
mice had gained markedly less weight, compared to theWT controls fed 
either RC or an HFD (Figure 1-7E). Furthermore, AHNAK KO mice had 
significantly reduced body fat contents and major fat pads of KO mice were 
significantly smaller than those of WT mice (Figure 1-8A, B). Adipocytes in 
KO mice contained a higher frequency of small adipocytes and a lower 
frequency of mid- and large-sized adipocytes than their WT counterparts 
(Figure 1-8C). In agreement, the expression of adipogenic-related genes 
such as Pparγ2, a key regulator of adipogenesis; aP2, a late adipocyte 
differentiation marker; and adiponectin, were reduced in eWAT from HFD-
` - 25 -
fed KO mice compared to WT mice. Furthermore, the expression of genes 
related to lipid metabolism, including Dgat2, Plin2, CD36, Lpl, and Hsl was 
significantly decreased in eWATs from HFD-fed KO mice (Fig. 1-8D). 





Figure 1-7. Role of AHNAK in obesity. (A) AHNAK expression in various 
tissues from 6-week-old C57BL6 mice (n=4–6). Values were normalized to Gapdh. 
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from 10-to12-week old male wild-type mice(n= 4) and normalized to 36B4. (C) 
AHNAK mRNA in epididymal WAT, inquinal WAT and BAT from wild-type mice 
fed RC or HFD (n=5-7 per group). (D) Comparison of body weights from wild 
type (Ahnak+/+) and hetero( Ahnak+/-) mice (n=3). (E) Changes in body weights 
during 12 weeks of feeding on RC or an HFD; n = 3 for WT and KO mice on 
regular chow diet (RC), n = 4 for WT and KO mice on HFD. 
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(A) Changes of body composition of WT and KO mice fed HFD analyzed 
by MRS (n=7-9). (B) Representative pictures of fat pads from mice fed an 
HFD. (C) H&E staining (left) of eWAT and distribution of adipocyte sizes 
(right); n=3 Scale bar, 200µm. (D) Relative mRNA levels of the indicated 
genes in WATs were measured by qPCR. Values were normalized to 36B4. 
WT: n=5, KO: n=8 The data shown are the mean±SEM. *P<0.05, **P<0.01, 
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 1.3.4. AHNAK KO mice are resistant to detrimental effect of 
obesity 
 
Gene profiling of eWAT from HFD fed AHNAK KO mice showed 
downregulation of inflammation mediated genes. On the other hands, 
insulin signaling, glucose metabolism, and thermogenic related genes are 
increased in AHNAK KO mice (Figure 1-9A). Consistent with gene profile 
analysis, macrophage infiltration in adipose tissue was evaluated by 
immunohistochemical staining using Mac-2 antibody. AHNAK KO mice 
showed less abundant macrophage infiltration (Figure 1-9B). To determine 
the source of this signal, we investigated inflammation related gene 
expression. Expression levels of inflammatory genes, such as CD68, F4/80, 
monocyte chemoattractant protein-1 (MCP1), IL6, and TNF-α were 
significantly down-regulated in eWAT of HFD-fed AHNAK KO mice with 
activation of M2 macrophage specific transcripts, including macrophage 
galactose N-acetyl-galactosamine specific lectin 2 (Mgl2), mannose receptor, 
C type 2 (Mrc2) and IL10 (Lumeng et al., 2007; Yadav et al., 2011)(Figure 
1-9C). AHANK ablation was also accompanied by a significant reduction of 
proinflammatory mediators such as IL-6, MCP-1, and PAI-1 in serum, as 
observed for adipose tissues (Figure 1-9D). 
 To assess the systemic effect of reduced adiposity in AHNAK KO 
mice, we measured lipid metabolism parameters in serum. The triglyceride 
levels were reduced in KO mice, although the FFA levels remained 
unchanged (Figure 1-10A,B). The levels of total and LDL-cholesterol were 
substantially decreased in HFD-fed KO mice (Figure 1-10C,D). Next, we 
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performed intraperitoneal GTT to determine the ability to clear glucose, 
with blood samples from RC- and HFD-fed mice. Glucose tolerance and 
insulin sensitivity were not significantly different in RC-fed mice (Figure 1-
11A,B). However, KO mice fed an HFD displayed lower blood glucose 
levels under fasting conditions and after glucose administration (Figure 1-
11C) than did WT mice. ITTs revealed that the blood-glucose lowering 
effect of insulin was slightly better in KO mice (Figure 1-11D). Key 
mediators of insulin signaling were examined to clarify the mechanisms of 
improved glucose metabolism in KO mice fed a HFD. The phospho-AKT 
levels in WAT, BAT, and gastrocnemius muscle, and phospho-IRb levels in 
liver increased in HFD-fed KO mice after insulin stimulation (Figure 1-
12A-D). Taken together, these results indicated that AHNAK-deficiency 
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Figure 1-9. Resistance to detrimental effect of obesity in AHNAK KO mice. 
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gene in eWAT from RC-or HFD-fed WT and KO mice (full dataset available online 
as NCBI GEO data set GSE37218). (B) Representative pictures of immunostaining 
of eWAT with antibody to Mac-2 (C) mRNA expression of inflammatory-related 
genes in mice fed HFD (n = 6-9). (D) Serum biochemistry of inflammatory profiles 







Figure 1-10. Serum lipid profiles from AHNAK KO mice.  
(A) Serum triglyceride. (B) FFA. (C) Total cholesterol. (D) LDL-cholesterol in WT 
and KO mice on an HFD. Serum levels were measured after a 16-h fasting period; 
n = 9/group (a-d). The data shown are the mean±SEM. *P<0.05, **P<0.01, 


















Figure 1-11. AHNAK KO mice exhibit enhanced glucose tolerance and insulin 
sensitivity.  
(A) Glucose tolerance after feeding on RC; WT: n=6, KO: n=4. (B) Insulin 
tolerance after of feeding on RC; WT: n=4, KO: n=6. (C) Glucose tolerance after 
an 8-week HFD; n = 9 for WT and n = 6 for KO mice. (D) Insulin tolerance after 
an 8-week HFD; n = 6 for WT and n = 6 for KO mice. The data shown are the 
mean values ± SEM, *P<0.05, **P<0.01, ***P<0.001 between WT and KO mice. 
C 
D 





Figure 1-12. Insulin signaling pathway in AHNAK KO mice. 
 HFD fed AHNAK KO mice and WT littermates were fasted overnight and then 
administered insulin (1.5U/Kg fo body weight) intraperitoneally. (A) eWAT, (B) 
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1.3.5. AHNAK KO mice show increased energy expenditure  
 
Changes in body weights often correlate with energy-balance alterations. 
The amount of calorie uptake/h in both RC- and HFD-fed mice was 
unaltered when normalized to body weight (Figure 1-13A). Serum leptin 
levels decreased in HFD-fed KO mice, despite their similar food intake 
(Figure 1-13B). These data suggested that leptin sensitivity was enhanced in 
KO mice and that the reduction in leptin levels in KO mice resulted from a 
reduction in fat mass, as leptin levels are associated with fat mass (Maffei et 
al., 1995). Despite similar food intake levels between the two groups, KO 
mice showed greater leanness and resistance to HFD-induced obesity. We 
thus hypothesized that KO mice have an increased metabolic rate or 
physical-activity rate. KO mice showed a slightly decreased level of activity 
(Figure 1-13C). Oxygen consumption and heat generation in KO mice were 
significantly increased compared to those of WT controls (Figure 1-13D,E). 
The RER remained unchanged in both groups (Figure 1-13F).  
 To confirm the effect of AHNAK ablation in WAT and BAT, we 
analyzed thermogenic gene expression profiles by qPCR. Thermogenic 
related genes, including Ucp1, Pgc-1, Cidea, Cpt2, and Adrb3, were 
significantly increased in eWAT and iWAT of HFD-fed AHNAK KO mice 
(Figure 1-14A,B). Notably, ablation of AHANK leads to upregulation of 
Adrb3 expression, which is essential for the regulation of adaptive 
thermogenesis and oxidative metabolism (Lowell and Bachman, 2003). 
Furthermore, histologic evaluation of BAT displayed slightly reduced lipid-
droplet accumulation in KO mice, compared to that in WT mice fed either 
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RC or an HFD (Figure 1-15A). However, the BAT weights between the two 
groups were comparable (Figure 1-15B). The expression of thermogenic 
genes was unaffected in BAT of KO mice fed a HFD, compared with that of 
WT mice (Figure 1-15C). These findings suggest that AHNAK ablation in 
WAT protects mice from obesity and its related complication accompanied 
by elevating energy expenditure.  
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Figure 1-13. AHNAK KO mice display increased energy expenditure. 
(A) Food intake (WT: n = 6, KO: n = 5). (B) Serum leptin concentrations (n=4). 
(C) Measurement of locomotor activity (WT: n=6, KO: n=5). (D) Whole-body 
oxygen consumption (VO2) over the course of 24 h (WT: n=6, KO: n=5). (E) 
Average value of heat generation (WT: n=6, KO: n=5). (F) The respiratory 
exchange rate was calculated as CO2 production/O2 consumption (WT: n=6, KO: 
n=5). (G) Relative mRNA expression of genes involved in energy dissipation and 
in brown adipose-specific genes in WAT, as measured by qPCR (n=6). Values were 
normalized to 36B4 expression. The data shown are the mean±SEM; *P<0.05, 
**P<0.01, ***P<0.001. 
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Figure 1-14. mRNA expression of thermogenic genes in eWAT (A) and iWAT 
(B) from HFD fed WT and KO mice (n=5). The data are presented as the means 









Figure 1-15. Phenotypic characteristics of BAT in AHNAK KO mice.  
(A) H&E staining of BAT. Scale bar, 200 µm; (B) Quantification of BAT mass 
(left) and BAT mass normalized by body mass (right); WT: n=5, KO: n=4. (C) 
Relative mRNA expression involved in energy dissipation and brown adipose 
specific genes in BAT measured by qPCR from mice fed an HFD for 12 weeks 
(n=5). Values were normalized to 36B4 expression. The data shown are 
means±SEM; *P<0.05, **P<0.01, ***P<0.001 
BA 
C 




 The physiological functions of AHNAK in adipose tissues have 
been unclear, although AHNAK is highly expressed in WAT. Here, we 
provide evidence that AHNAK acts as a critical regulator of adipogenesis in 
vitro and in vivo. Studies on the role of Ahnak in adipose tissue have 
reported conflicting results. Alli and coworkers claimed that decreased 
AHNAK1 expression observed during adipocyte differentiation in 3T3-L1 
cells indicated that AHNAK negatively regulates adipogenesis (Alli and 
Gower, 2009). In contrast, AHNAK gene expression was increased 6-fold in 
adipose tissue during early-phase obesity in rats (Li et al., 2002). Previous 
findings have demonstrated elevated AHNAK levels in WAT from mice 
with genetically or environmentally induced obesity (Li et al., 2002; 
Ramdas et al., 2015). Consistent with previous murine-model studies, 
AHNAK expression significantly increased in the fat tissues of obese 
human subjects. 
 Loss of AHNAK resulted in lowered fat-cell formation due to 
suppressed SMAD1/5 phosphorylation and nuclear translocation. Our 
results indicated that AHNAK regulates adipocyte differentiation by 
modulating BMP-induced canonical SMAD signaling. SMAD1 inactivation 
in AHNAK-deficient ADSCs led to impaired Ppar2 transcription. Our data 
indicate that AHNAK is required for adipocyte differentiation via SMAD11 
binding to the Ppar2 promoter following BMP4 stimulation. Similar to 
AHNAK, SCHNURRI-2 interacts with SMAD1 and controls adipogenesis 
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through Ppar2 transcriptional activation (Jin et al., 2006). Although 
additional studies are required to elucidate the function of AHNAK-
dependent SMAD1 signaling in adipose hypertrophy in vivo, previous 
evidence has shown that BMP/SMAD signaling promotes adiposity by Tob2 
expression in mice (Takahashi et al., 2012). 
 Adipose tissue is composed of adipocytes and the stromal vascular 
fraction, which contains preadipocytes, mesenchymal stem cells, endothelial 
cells, and macrophages (Riordan et al., 2009). Adipocyte precursor cells in 
the stromal vascular fraction are capable of differentiation into mature 
adipocytes (Rodeheffer et al., 2008). BMPs have crucial roles in cell fate-
determinations of multipotent mesenchymal stem cells (Gesta et al., 2007). 
BMPs regulate gene expression of Runx2, Ppar2, Sox9, and MyoD, which 
are master regulators of lineage determination that control embryogenesis 
and organogenesis (Blitz and Cho, 2009; Pan et al., 2008; Phimphilai et al., 
2006; Reshef et al., 1998; Zehentner et al., 1999; Zhao, 2003). Together, 
these findings imply that AHNAK present in the stromal vascular fraction of 
adipose tissue may explain the decreased AHNAK levels observed during 
adipogenesis, as well as the restricted adipogenic commitment and 
differentiation in AHNAK-KO mice. However, it remains unclear how 
AHNAK controls BMP4/SMAD1 signaling during mesenchymal 
differentiation into other cell types, such as the osteogenic, chondrogenic, 
and myogenic lineages. Furthermore, it would be interesting to determine 
whether AHNAK regulates BMP4 signal transduction via other inhibitory 
mechanisms such as BMP receptors, I-SMAD (SMAD6/SMAD7), or 
ubiquitination.  
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 Previous studies reported that AHNAK activates PLC-1-PKCa and 
contributes to mitogenic signaling in response to growth factors (Lee et al., 
2008; Lee et al., 2004). The AHNAK protein controls cell cycle progression 
through c-MYC, which is highly expressed in AHNAK deficient MEF cells 
(Lee et al., 2014). Cell proliferation, arrest, cell-cycle re-entry, and 
differentiation by hormonal stimulation are crucial processes during 
adipogenesis (Fajas, 2003). Consistently, increased levels of c-MYC lead to 
the inhibition of adipocyte differentiation by blocking cell cycle arrest in 
3T3-L1 cells (Reichert and Eick, 1999). Therefore, it would be interesting to 
uncover the link between AHNAK and c-MYC in 3T3-L1 cells, which are 
committed to an adipogenic lineage. 
 While we focused on the role of AHNAK in adipogenesis, our data 
also implicate AHNAK in energy and glucose homeostasis. Recent evidence 
showed that AHNAK expression inversely correlates with oxygen 
consumption (Parikh et al., 2008b). Whole-body oxygen consumption and 
energy expenditure were significantly elevated in HFD-fed KO mice 
accompanied by increased levels of thermogenesis-related genes (Ucp1, 
Dio2, and Adrb3) and oxidation-related genes (Pparα and Pparβ/δ) in WAT, 
but no difference was found in BAT, which mainly controls heat generation. 
Adiposity influences systemic insulin resistance (Griffith et al., 2010). Here, 
we demonstrated that AHNAK KO mice are protected against HFD-induced 
insulin resistance, with reduced fat accumulation. A recent study showed 
that mice lacking AHNAK were glucose intolerant (Ramdas et al., 2014), 
and we also found that HFD-fed AHNAK-KO mice displayed markedly 
lower fasting insulin levels (Fig. 5G). This reduction suggests that the 
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increased glucose tolerance in AHNAK-KO mice was attributable to insulin 
sensitivity. Furthermore, our hyperinsulinemic/euglycemic clamp 
experiments revealed that HFD-fed AHNAK-KO mice displayed increased 
insulin-mediated suppression of hepatic glucose output, with higher glucose 
uptake in the peripheral tissues (Shin et al., 2015). In this regard, AHNAK 
deficiency also resulted in significantly improved glucose-disposal rates 
with a robust increase in insulin signaling in target tissues. These results 
may have been due to a difference in the fat contents of the diets. The 
authors performed their experiments with a lower fat-containing diet than 
was employed in the current study. Another possibility is that the mice had a 
different genetic background, which can influence metabolism in mice 
(Vaillant et al., 2014). While our mutant mice were derived from a C57BL/6 
background, their mice originated from BDF1, a cross between female 
C57BL/6 and male DBA/2. Our mutant mice could display better glucose 
tolerance and greater responsiveness to insulin, because BDF1 mice are 
prone to develop obesity-induced diabetes more than B6 mice (Karasawa et 
al., 2011).  
 Results from this study demonstrated that AHNAK downregulation 
protects mice from obesity, hepatosteatosis, and insulin resistance. 
Furthermore, although AHNAK is implicated in the regulation of energy 
metabolism and glucose homeostasis, further studies are needed to 
determine the molecular mechanism whereby AHNAK regulates energy 
metabolism. We cannot exclude the possibility that AHNAK may influence 
other tissues or mouse development because we used mice carrying the null 
mutation. In particular, studying tissue-specific AHNAK inactivation will 
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likely be useful in that indirect effects may be involved in the overall 
regulation of adiposity and energy metabolism. Moreover, it should be 
determined whether AHNAK overexpression contributes to aggravated 
obesity and metabolic homeostasis. 
 






Increased levels of eosinophils and type II 
cytokines in WAT mediates the browning and 













Figure 2-1. Types of adipose tissue. (Pfeifer et al. Annu. Rev. Pharmacol. 2015) 
  
 
 Obesity is associated with several metabolic disorders including 
type 2 diabetes, cardiovascular disease (Despres and Lemieux, 2006; Eckel 
et al., 2005; Grundy, 2006). Mammalian adipose tissue has been 
traditionally divided into two distinct types. WAT stores excessive energy in 
unilocular adipocytes. On the other hands, brown adipose tissue (BAT) 
dissipates energy through nonshievering thermogenesis in multilocular 
adipocytes (Cinti, 2001; Harms and Seale, 2013; Rosen and Spiegelman, 
2014). Brown adipocytes generate heat and conteract obesity due to 
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containing abundant mitochondria and UCP1. Recently, alternative type of 
fat cell termed “beige adipocyte” or “browning” is emerging from several 
studies (Figure 2-1) (Bartelt and Heeren, 2014; Ishibashi and Seale, 2010; 
Wu et al., 2012). These beige fat cells exist within white adipose depots and 
share common morphological and functional features with classical brown 
adipocytes. Thus, there has been emerging interest in beige fat as an anti-
obesity therapeutic potential (Harms and Seale, 2013; Pfeifer and Hoffmann, 
2015; Yoneshiro et al., 2013).  
 Several secreted factors, such as Irisin, BMP8b, T4, natriuretic 
peptides and noradrenalin that induce browning in WAT have been reported 
(Figure 2-2) (Bordicchia et al., 2012; Bostrom et al., 2012; de Jesus et al., 
2001; Harms and Seale, 2013; Hondares et al., 2011; Nguyen et al., 2011a; 
Whittle et al., 2012). Previous studies suggest that b-adrenergic signals 
including noradrenalin and b-adrenergic agonist enhance lipolysis and 
adaptive thermogenesis (Atgié et al., 1998; Bachman et al., 2002; 
Granneman et al., 2005; Himms-Hagen et al., 1994). Three adrenergic 
receptors mediate thermogenesis via sympathetic nerve activation. Of these 
receptors, especially, 3 specific adrenergic receptors (Adrb3) alleviated 
obesity and diabetes (Arch and Wilson, 1996; Kim et al., 2006). Adrb3 are 
abundant in rodent adipose tissue (Lowell and Bachman, 2003; Nahmias et 
al., 1991). CL316243, 3 adrenergic receptor agonist has been utilized to 
mimic the effect of browning (Himms-Hagen et al., 2000; Schulz et al., 
2013). CL-316243 in adipocytes stimulates cyclic AMP (cAMP) production, 
which binds to the protein kinase A (PKA). Activation of PKA has been 
considered as a mediator for UCP1 and PGC1 expression for 
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thermogenesis (Cao et al., 2001; Collins et al., 2010). 
 We recently reported that AHANK KO mice exhibit enhanced 
insulin sensitivity and higher energy expenditure under high fat diet (Shin et 
al., 2015). This was accompanied by reduction of whole body fat 
accumulation. The levels of Ucp1 mRNA were increased in eWAT from 
HFD fed AHNAK KO mice, compared with that of wild-type control mice. 
Although AHNAK is highly expressed in adipose tissue and increased obese 
murine models (Li et al., 2002; Ramdas et al., 2014), thermogenic function 
of AHNAK in adipose tissue has not been determined.  
In the present study, we demonstrated that AHNAK ablation results in 
activation of eosinophils and type 2 cytokines which contribute to browning 
of WAT depot and promotes energy expenditure by ADRB3 agonist (CL-
316243) treatment. 
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Figure 2-2. Secreted factors that recruit beige adipocytes. (Harms et al. Nat 
Med. 2013) 
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AHNAK-KO (Ahnak-/-) mice were maintained under a 12-h light-dark cycle 
and had free access to water in a specific pathogen-free barrier facility. Mice 
were randomly assigned. To stimulate the browning of white adipose depots, 
2-3 month-old mice were treated with daily intraperitoneal injections of 
1mg/kg bodyweight CL-316,243 (Sigma-Aldrich) dissolved in PBS. The 
experiments were performed according to the “Guide for Animal 
Experiments” (Edited by Korean Academy of Medical Sciences) and 
approved by the Institutional Animal Care and Use Committee (IACUC) of 
the Seoul National University (Permit Number: SNU-130903-1). 
 
Core body temperature measurement 
Body temperature was measured with telemetry transmitters (TSE Systems). 
A transmitter was implanted into peritoneal cavity under anesthetics.  
 
Indirect calorimetry study 
Oxygen consumption (VO2), carbon dioxide production (VCO2), 
respiratory exchange ratios (RER) and heat production were measured using 
an indirect calorimetry system (TSE) installed. Mice in each chamber were 
maintained under 12h light/dark cycle with a constant environmental 
temperature (22 °C) and free access to food and water. 
 
Immunostaining 
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Adipose tissue samples were fixed in 4% paraformaldehyde and embedded 
in paraffin, sectioned and stained. Primary antibodies were incubated 
overnight at 4℃. Images were captured using a confocal microscope system 
(LSM 710, Carl Zeiss). 
 
Immunoblotting  
For immunoblot analysis, cells were lysed in PRO-PREP buffer (iNtRON 
Biotechnology Inc., Seoul, Korea) containing a phosphatase-inhibitor 
cocktail (GenDEPOT, Barker, TX, USA). Protein extracts were separated by 
sodium dodecyl sulfate-polyacrylamide gel electrophoresis, transferred to a 
polyvinylidene fluoride membrane (Millipore, Billerica, Massachusetts, 
USA), and subjected to immunoblot analysis. Immunoblot analysis was 
performed using the indicated antibodies. Proteins were visualized by ECL 
chemiluminescence (AbClon, Seoul, Korea). GAPDH was detected as a 
loading control. Immunoreactive signals were detected through their 
enhanced chemiluminescence and recorded using the MicroChemi 4.2 
system (DNR Bio-Imaging Systems, Jerusalem, Israel). 
 
Antibodies  
The primary antibodies used for western blot analysis were specific for: 
UCP1, PGC1α, CPT2, PPARα, AHNAK, and OXPHOS (oxidative 
phosphorylation) complexes (all from Abcam); GAPDH (Cell Signaling 
Technology, Beverly, MA, USA); PDGFRa (R&D Systems, UK); and 
Tyrosine hydroxylase (Millipore). 
DAPI (ImmunoBioScience Co., Washington, USA) was used for nuclear 
staining. 
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Cell preparations and flow cytometric analysis 
Epididymal white adipose tissues were chopped with scissors for 4 minutes. 
These are added 2mL Collagenase II (SIGMA C6885, 400U/mL) and 
incubated at 37℃ for 8 minutes. After digestion, single-cell suspensions 
were treated with 20μL of 0.5M EDTA and filtered using 70 μm meshes. 
The cells were centrifuged 385g for 10 minutes at 4℃ to remove floated 
adipocytes, and red blood cells were lysed by 1X RBC lysis buffer 
(eBioscience 00-4300-54) for 2 minutes on ice. After blocking Fc receptors 
using TruStain FcXTM (Biolegend 101320), the cells were stained with the 
indicated fluorochrome conjugated antibodies. We used an LSRFortessa™ 
(BD) or FACSCanto™ II (BD), and analyzed flow cytometric data with 
FlowJo (Tree Star Inc). The antibody used in flow cytometry were PE 
conjugated PDGFRα (eBioscience 12-1401-81), PE conjugated IgG2a,κ 
(Biolegend, 400507), PerCP conjugated CD45 (Biolegend, 103130), PE/cy7 
conjugated CD11c (Biolegend, 117318), APC conjugated CD11b 
(Biolegend, CD11b), APC conjugated CD44 (Biolegend, 103012), and 
BV421 conjugated siglecF (BD HorizonTM, 562681). 
 
Statistics  
All values were expressed as the mean± SEM. Statistical analysis was 
performed using the Student’s t-test between two groups. The Kruskal-
Wallis Test was used for Flow cytometric analysis. P<0.05 was considered 
significantly. 
 





2.3.1 AHNAK ablation promotes thermogenic gene program 
and browning in WAT but not in BAT via -adrenergic 
stimulation 
 
To evaluate cold-induced adaptive thermogenesis in AHNAK KO mice, they 
were exposed to an ambient temperature of 4°C for 3 days and compared to 
the animals kept at thermoneutral conditions (30°C). AHNAK expressioin 
was selectively downregulated in eWAT and iWAT (p<0.07) (Figure 2-3A). 
Similary, the decrease of AHNAK mRNA was observed in fully 
differentiated 3T3-L1 after 6h exposure to 30°C compared with cells kept at 
37°C (Figure 2-3B). At 30°C, AHNAK KO mice had few UCP1-positive 
adipocytes and their morphology was similar to that of the wild-type mice. 
However, after cold exposure, AHNAK KO mice demonstrated an increase 
in multilocular UCP1-expressing adipocytes in eWAT and inguinal iWAT 
(Figure 2-4). Both eWAT and iWAT but not BAT from AHNAK-deficient 
cold-exposed mice tended to have higher mRNA levels of thermogenic 
genes (Pgc1, Cidea, Dio2, Cpt1); in addition, eWAT in these mice was 
enriched in beige adipocyte markers (CD137, Tmem26) compared to the 
wild-type mice after cold exposure (Figure 2-5A–C). These results suggest 
that AHNAK genetic ablation promotes adaptive browning of WAT under 
environmental stimulation. 
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 The sympathetic nervous system (SNS) plays a critical role in BAT 
activation and adaptive thermogenesis mediated by -adrenergic receptors 
(Lowell and Bachman, 2003; Robidoux et al., 2004). To examine whether -
adrenergic signaling influenced thermogenesis in AHNAK KO mice, they 
were administered CL-316243 (CL), an ADRB3 agonist. We found 
significantly lower expression of AHNAK in the eWAT and iWAT under CL 
treatment, but not BAT (Figure 2-6A). Histological analysis revealed that 
CL induced WAT of AHNAK KO mice resulted in morphological 
transformation of unilocular adipocytes to multilocular UCP1-expressing 
adipocytes, compared with that of wild-type controls. (Figure 2-6B,C). At 
the mRNA level, the expression of both brown adipocyte related genes 
(Ucp1, Cidea, Dio2 and Pgc1) and mitochondrial genes (Cpt1, Cpt2 and 
Cox8b) was higher in the CL-stimulated eWAT and iWAT of AHNAK KO 
mice than WT mice (Figure 2-7A,B). Immunoblot analysis showed that 
UCP1, PGC1α and CPT2 were significantly elevated both in eWAT and 
iWAT from CL-stimulated AHNAK KO mice compared to that from WT 
mice (Figure 2-8A,B). However, there were no obvious changes in the 
histological morphology and activity of BAT between WT and AHNAK KO 
mice (Figure 2-6A, 2-7C, 2-8C). Furthermore, AHNAK KO mice exhibited 
higher core body temperature than wild-type mice after CL injection (Figure 
2-9). Consistent with a previous report (Parikh et al., 2008a), oxygen 
consumption (VO2) and energy expenditure were significantly elevated in 
AHNAK KO mice compared to WT mice after CL stimulation (Figure 2-
10A,B). These results suggest that 3-adrenergic stimulation mediates the 
formation of multilocular adipocytes and enhances adaptive thermogenesis 
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through upregulation of thermogenic genes in the AHNAK deficient WAT 
depots, leading to increased energy expenditure. 




Figure 2-3. AHNAK mRNA expression by qPCR during cold chanllege.  
(A) Expression levels of AHANK gene in fat depots (n=5). (B) 3T3-L1 cells were 
differentiated and maintained in for 10d (day 0–10) qPCR analysis of differentiated 
3T3-L1 cells following maintaining in  37 °C or 30 °C for 6h (n=4). Values were 
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Figure 2-4. Browning phenotype of WAT in AHNAK KO mice under cold 
exposure. Representative pictures of UCP1 immunostaing in adipose tissues from 
mice maintained at 30°C (warm) or 4°C (cold) for 3 days. by cold exposure for 
3days at 4°C. 
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Figure 2-5. Expression of thermogenic related genes in AHNAK KO mice 
under cold exposure. 
qPCR analysis in eWAT (A), iWAT (B) and BAT(C) from mice (n=5-6). Values 
were normalized to 36B4. Data are means ± SEM; *P<0.05, **P<0.01, 









Figure 2-6. Ablation of AHANK induces white to brown fat transition. 
(A) AHNAK mRNA expression of fat depot in control or CL treated mice 
(n=4-9 per group) and normalized to 36B4. (B) Representative hematoxylin 
and eosin staining of adipose tissues from mice treated with CL316243 (CL) for 3 
days. (C) Immunofluorescence staining of UCP1 in adipose tissues of mice treated 
or not with CL CL-316243.  
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Figure 2-7. Expression of thermogenic related genes in AHNAK KO mice 
under CL-challenges.  
(A-C) qPCR analysis of thermogenic related genes in eWAT (A), iWAT (B), and 
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**P < 0.01, ***P < 0.001, wild-type (WT) versus Ahnak-/- (KO) mice. 
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Figure 2-8. Thermogenic gene expression in AHNAK KO mice.  
(A-C) Immunoblot analysis of eWAT (A), iWAT (B), and BAT (C) from mice 
treated with 3-day CL316243. The data are presented as the means ± SEM. *P < 









Figure 2-9. Measurement of body temperature in AHNAK KO mice after CL 
challege.  
Core body temperature measured for WT and KO mice after CL injection at room 
temperature (n=12). The data are presented as the means ± SEM. *P < 0.05, **P < 
0.01, ***P < 0.001, wild-type (WT) versus Ahnak-/- (KO) mice. 




Figure 2-10. Enhanced thermogenesis in AHNAK KO mice after CL challenge.  
(A) Oxygen consumption (VO2) and (B) heat generation before and after CL-
316243 injection (n = 7 per group). The data are presented as the means ± SEM. *P 
< 0.05, **P < 0.01, ***P < 0.001, wild-type (WT) versus Ahnak-/- (KO) mice. 
A 
B 
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 In addition, ADRB3 stimulation has been associated with the 
reduction of fat mass and induction of mitochondrial biogenesis (Mottillo et 
al., 2007). To examine whether in AHNAK-deficient WAT the increase in 
energy expenditure and UCP1 expression was associated with mitochondrial 
activation, we investigated the changes in mitochondrial biogenesis in 
adipose tissues. The levels of the OXPHOS genes in the mitochondrial 
respiratory complexes I–V were remarkably increased in WAT of CL-treated 
AHNAK KO mice compared to the wild-type animals (Figure 2-11A,B); 
however, in BAT no significant effect was observed (Figure 2-12). Thus, 
increased mitochondrial function represented by the upregulation of the 
OXPHOS genes may underlie induced higher energy expenditure, and 
metabolic activity in AHNAK-deficient WAT.  
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Figure 2-11. Mitochondrial biogensis of WAT in AHNAK KO mice 
Immunoblotting analysis of mitochondrial respiratory chain complexes in eWAT 
(A) and iWAT (B); GAPDH was used as a loading control. The data are presented 
as the means ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001, wild-type (WT) versus 
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Figure 2-12. Mitochondrial biogensis of BAT in AHNAK KO mice 
Immunoblot analysis of mitochondrial respiratory chain complexes in BAT of CL-
treated mice (n=5). GAPDH was used as a loading control. Data are mean values ± 
SEM, *P<0.05, **P<0.01, ***P<0.001 between WT and KO mice. 
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2.3.2. Increased levels of eosinophils and type 2 cytokines in 
AHNAK deficient WAT 
 
 We observed phenotypic change into a brown-like adipocyte in CL-
stimulated AHNAK deficient WAT although we used mice with a null 
mutation. We therefore hypothesize that this enhanced thermogenesis by -
adrenergic signaling can be induced by non-adipose progenitor cell types. 
Recent studies have focused on the eosinophil mediated regulation of beige 
fat development (Brestoff et al., 2014; Lee et al., 2015b; Qiu et al., 2014). 
To investigate whether eosinophils mediate WAT browning induced by -
adrenergic stimulation, we isolated eWAT and identified cell lineages that 
express sialic acid-binding immunoglobulin receptor (Siglec-F) and CD11b 
as molecular markers for eosinophils (Figure 2-13A). CL exposure 
increased the frequency and number of Siglec-F+/CD11b+ cells representing 
eosinophils in AHNAK-deficient eWAT (Figure 2-13B,C). Consistently, 
mRNA levels of eosinophil (Siglec-F and Ccr3), type 2 cytockines (IL-4, 
IL-4ra, and IL-13) and alternatively activated M2 specific gene (IL-10) were 
also significantly increased in eWAT and iWAT of CL-treated AHNAK KO 
mice(Figure 2-13D,E), but not in BAT (Figure 2-13F). Eosinophils and type 
2 cytokines are implicated in regulating the biogenesis of thermogenic beige 
fat (Nguyen et al., 2011b; Qiu et al., 2014). This increase was accompanied 
by significant increase of PDGFRa+/CD44+ progenitor cells in Ahnak KO 
mice (Figure 2-14A,B). PDGFRa+ cells were identified as a bipotential 
progenitor differentiating white or beige adipocytes (Lee et al., 2012b). 
Together, these results indicate that genetic ablation of AHNAK augments 
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eosinophil content and type 2 cytokine signals in CL-treated WAT, which 





   
 
 




Figure 2-13. Increased levels of eosinophils and type 2 cytokines in AHANK 
deficient WAT.  
(A) Gating strategy for identification of eosinophil lineage defined as CD45+ 
CD11b+ Siglec F+. (B,C) Representative plots and frequencies (B) and number (C) 




` - 73 -
from 7-10 mice). Statistical analysis was performed using the Kruskal-Wallis Test 
(***P<0.001) 
(D-F) qPCR analysis of eosinophil and type 2 cytokine related gene in eWAT (D),  
iWAT (E) and BAT (F) of mice treated with CL-316243 (n= 5-7) and normalized to 
36B4. Data are means ± SEM; *P<0.05, **P<0.01, ***P<0.001 
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Figure 2-14. PDGFRa+ CD44+ progenitor cells in AHNAK deficient eWAT of 
Cells.  
(A, B) Representative plots (A) and frequencies (B) of progenitor cells in eWAT of 
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2.4. DISCUSSION 
 
 Understanding of signaling pathways that regulate thermogenesis 
and enhance energy expenditure, and identification of their potential targets 
is important for the development of measures to control obesity. It has been 
suggested that the activation of brown adipocytes and increase of BAT mass 
may constitute effective strategies to counteract obesity (Pfeifer and 
Hoffmann, 2015; Yoneshiro et al., 2013). Recent studies have reported 
catecholamine resistance in adipose tissue could be associated with obesity 
(Guo et al., 2014; Jocken et al., 2008). AHNAK-deficient mice displayed 
increased energy expenditure during high fat diet challenge, indicating 
resistance to obesity (Shin et al., 2015). Here, we revealed a critical role of 
AHNAK in regulating browning of WAT in response to-adrenergic 
stimulation. AHNAK deficiency promotes the increase of functional brown-
like adipocytes in WAT depots, which results in higher energy expenditure 
following3-adrenergic stimulation.  
 ADRB3 agonists have been recognized as critical mediators of 
lipolysis and thermogenesis. ADRB3-activated PKA stimulates a 
transcriptional coactivator PGC1 leading to increased UCP1 expression 
and thermogenesis (Collins et al., 2010; Fredriksson et al., 2001). Efforts 
have been made to develop therapeutic approaches targeting ADRB3 to 
fight obesity and metabolic disorders, and CL-316243 has been used for 
generating brown-like adipocytes in WAT (Granneman et al., 2005; Lee et 
al., 2012b). However, the development of such drugs has been challenging 
because of insufficient oral bioavailability and cross-reactivity with ADRB1 
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(Arch, 2002, 2011). Nevertheless, new ADRB3 agonists have been 
investigated in clinical trials and shown improved bioavailability and 
binding affinity (Cypess et al., 2009; Cypess et al., 2015; Larsen et al., 
2002; Redman et al., 2007). Several factors have been reported to be 
involved in fat browning and thermogenesis. PGC1 has been recognized 
as a key regulator of energy metabolism and mitochondrial biogenesis. 
PGC1activation regulated by mitogen-activated protein kinase p38 
enhances the expression of thermogenic genes in adipose tissues in response 
to β-adrenergic signaling (Cao et al., 2004). It has been shown that Pgc1-/- 
mice exhibited abnormal thermogenic phenotype, suggesting that PKA 
activation which regulates PGC1 expression mediates thermogenesis 
(Leone et al., 2005). CPT2 is a crucial regulator of long chain fatty acid 
transport and is involved in initiation of -oxidation in mitochondria. Mice 
overexpressing vitamin D receptor had reduced energy metabolism, which 
correlated with the downregulation of fatty acid oxidation and lipolysis, and 
suppression of CPT2 in WAT (Wong et al., 2011). Mice with adipose tissue-
specific CPT2 ablation are defective in cold- or CL-induced thermogenesis 
because of deregulation of fatty acid oxidation, suggesting that CPT2 
increase underlies enhanced lipolysis and thermogenesis in AHNAK KO 
mice (Lee et al., 2015a).  
 Local thermogenic circuit involving eosinophils and type 2 
cytokines activates WAT browning and induces thermogenesis (Brestoff et 
al., 2014; Qiu et al., 2014), while the inhibition of tyrosine hydroxylase, a 
rate-limiting enzyme of catecholamine biosynthesis, or IL-4/13 signaling 
causes disruption of browning-related responses IL-4/13 signaling or 
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tyrosine hydroxylase (TH), a rate-limiting enzyme of catecholamine 
biosynthesis, causes the disruption of browning response (Qiu et al., 2014; 
Rao et al., 2014). Here, we investigated the process of generating functional 
beige cells in AHNAK-deficient WAT. AHNAK ablation led to robust 
recruitment of eosinophils into WAT and induced the secretion of 
eosinophil-derived cytokines after -adrenergic stimulation, resulting in the 
production of epinephrine accompanied by increased expression of IL-10 
and tyrosine hydroxylase, which promotes WAT browning and enhances 
mitochondrial biogenesis. It is still unclear whether eosinophils are 
regulated in an AHNAK-dependent manner because these parameters are 
also increased in unstimulated AHNAK-deficient eWAT. These results 
suggest that the increase in eosinophils and cytokine (IL-4/IL-13) secretion 
by adipocyte precursors could lead to catecholamine-induced WAT 
browning in AHNAK KO mice.  
 






Effect of enhanced -adrenergic and NPs 








Lipolysis in adipocytes is important reactions in the management for energy 
reserves. Nonesterified fatty acids (NEFAs) are released by lipolysis of 
adipose tissue triacylglycerols (TAG) stored in the adipocytes. They serve as 
a source of energy during fasting and conditions of stress. After TAG 
hydrolysis, NEFAs and glycerol are transported by the bloodstream to other 
tissues. However, some NEFAs generated during lipolysis are re-esterified 
in a futile cycle back into the adipocytes as intracellular TAG (Lafontan et 
al., 2005). The glycerol formed during lipolysis is mainly used as an 
important substrate for glucose synthesis by the liver. Lipolytic reactions are 
controlled by catecholamines and insulin. Natriuretic peptides (NPs) which 
are involved in regulation of salt and water balance and blood pressure 
homeostasis, has been reported to have potent lipolytic effects (Figure 3-1) 
(Lafontan et al., 2005). In adipocytes, catecholamines stimulate lipolysis 
mainly through increase in cAMP and PKA activation, which 
phosphorylates HSL and perilipin, a protein coating the lipid droplet (Figure 
5) (Deiuliis et al., 2010; Holm, 2003).  
There are three members of the cardiac natriuretic peptides (NPs) family; 
atrial NP (ANP) was identified and synthesized in heart atria, brain NP 
(BNP) was isolated from porcine brain and mainly secreted from the heart 
ventricles, and C-type NP (CNP) is not only expressed in the central nervous, 
but also endothelial cells and chondrocytes (Lafontan et al., 2005). Their 
actions are mediated by binding to 3 subtypes of NP receptors (NPR) which  
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Figure 3-1. Major pathways involved in the control of human fat cell lipolysis. 
(Lanfontan et al., Arterioscler Thromb Vasc Biol, 2005) 
  
 
either possesse guanylyl cyclase (GC) activity (NPR-A and NPR-B) to 
generate the second messenger cGMP or do not (NPRC, which is referred to 
as the clearance receptor) (Bordicchia et al., 2012; Chinkers et al., 1989). 
Previous studies reported that NPs showed potent lipolytic effects similar to 
those induced by the -AR agonist (Sengenès et al., 2002; SENGENÈS et 
al., 2000). Notably, the levels of NPRC in adipose tissue were decreased in 
the fasting condition in rats (Sarzani et al., 1995). A physiological role for 
NPs in exercise-induced lipolysis in humans suggest that heart has a central 
role in regulating the supply of fatty acids for both cardiac and skeletal 
muscle under aerobic conditions (Moro et al., 2004; Moro et al., 2006). 
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Several studies reported that NPs have also been associated with obesity 
(Chen-Tournoux et al., 2010; Sugisawa et al., 2010). NPs are implicated in 
brown fat thermogenesis in adipocytes via cGMP and PKG, as effectively as 
catecholamines through cAMP and PKA (Bordicchia et al., 2012). 
 In this study, the effects of elevated sympathetic tones and NPs 
signaling on lipolysis in AHNAK KO mice were investigated. 
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3.2. Materials and Methods 
Animals 
AHNAK-KO (Ahnak-/-) mice were maintained under a 12-h light-dark cycle 
and had free access to water in a specific pathogen-free barrier facility. Mice 
were randomly assigned. To stimulate the liplysis of white adipose depots, 
2-3 month-old mice were treated with daily intraperitoneal injections of 
1mg/kg bodyweight CL-316,243 (Sigma-Aldrich) dissolved in PBS. The 
experiments were performed according to the “Guide for Animal 
Experiments” (Edited by Korean Academy of Medical Sciences) and 
approved by the Institutional Animal Care and Use Committee (IACUC) of 
the Seoul National University (Permit Number: SNU-130903-1). 
 
Lipolysis assay 
To assess in vivo lipolysis, serum free fatty acids (FFAs) were measured in 
cardiac blood obtained from non-fasted mice before and 20 min after i.p. 
injection of CL316243 (1 mg/kg). Ex vivo and in vitro lipolysis was 
measured as described previously (Guo et al., 2013; Guo et al., 2014) with 
some modifications. Briefly, for ex vivo analysis, adipose tissues were 
surgically removed from male and female mice, weighed, and washed with 
cold PBS; fat depots were incubated with CL316243 (1 M) or vehicle in 
Krebs-Ringer Bicarbonate Buffer (KRBH, Sigma) containing 1% fatty acid-
free BSA (GenDEPOT) and glucose (2.5 mM) for 2 h at 37°C with mild 
shaking. After incubation, FFA and glycerol were measured using a 
glycerol-free reagent (Sigma) and the FFA quantification kit (BioVision, 
Mountain View, CA, USA) and normalized to the weight of adipose tissue 
samples. For in vitro lipolysis, differentiated 3T3-L1 adipocytes were 
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transfected with Ahnak-specific siRNA (Bioneer) and negative control 
siRNA and incubated with CL316243 (1 M) or vehicle in KRBH for 3 h at 




The primary antibodies used for western blot analysis were specific for: 
pHSL, HSL, pPKA substrates, and GAPDH (all from Cell Signaling 
Technology, Beverly, MA, USA) 
 
Statistics  
All values were expressed as the mean± SEM. Statistical analysis was 
performed using the Student’s t-test between two groups. P<0.05 was 
considered significantly. 
 




3.3.1. Enhanced -adrenergic signaling lipolysis in WAT of 
AHNAK KO mice treated with CL-316243 
 
 Stimulation of 3-adrenergic receptor agonist induces activation of 
protein kinase A (PKA), which then leads to lipolysis mediated by 
phosphorylation of hormone sensitive lipase (HSL) (Deiuliis et al., 2010). 
Therefore, we investigated catecholamine signaling in adipose tissue of CL-
treated AHNAK KO mice. There was no difference in serum concentration 
of free glycerol between AHANK KO and wild type mice after CL injection 
probably because of a decrease in body fat in AHNAK KO mice (Figure 3-
2A). However, the exposure to CL316243 resulted in a higher fold increase 
in glycerol release in AHNAK KO mice than wild type mice (Figure 3-2B). 
Importantly, AHNAK deficient WAT also displayed increased expression of 
tyrosine hydroxylase, the rate-limiting enzyme in the synthesis of 
catecholamines (Figure 2-8A,B). Moreover, circulating levels of 
epinephrine were also increased in KO mice (Figure 3-2C), suggesting that 
white fat browning may be attributed to enhanced sympathetic input to WAT 
in AHNAK-deficient mice. Moreover, Adrb3 mRNA expression was 
significantly increased after CL stimulation in WAT but not in BAT of 
AHNAK KO mice (Figure 3-3A). However, the levels of other adrenergic 
receptor subtypes, Adrb1 and Adrb2 were not altered (Figure 3-3B,C). 
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Previously decribed (Nunn et al., 2010), the levels of Rgs2, a negative 
regulator of adrenergic signaling, also displayed no differences between the 
two groups (Figure 3-3D). These results suggest that robust sympathetic 
tone and enhanced catecholamine sensitivity may alter -adrenergic 
responsiveness in AHNAK-deficient WAT. In agreement with this notion, 
PKA activity in WAT was substantially elevated in AHNAK KO mice as 
evidenced by the increase in the level of phosphorylated PKA substrates and 
hormone sensitive lipase (HSL) in both eWAT and iWAT of AHNAK-
deficient mice after CL injection (Figure 3-4A,B); however, no changes 
were observed in BAT (Figure 3-5). Further, AHNAK KO mice exhibited 
higher CL-stimulated lipolytic response after HFD feeding (Figure 3-6A,B). 
Thus, AHNAK may regulate catecholamine sensitivity in WAT. 
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Figure 3-2. Enhanced -adrenergic signaling in WAT of AHNAK KO mice. 
(A) CL-316243 stimulated glycerol levels in serum from RC fed mice (20 min after 
CL injection) (n=5). (B) Fold changes of glycerol levels over basal after CL316243 
stimulation s in serum (n=5). (C) Serum epinephrine (n = 7–9 for basal, n = 17–20 
for CL). The data are presented as the means ± SEM; *P < 0.05, **P < 0.01, ***P 
< 0.001, wild-type (WT) versus Ahnak-/- (KO) mice.
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Figure 3-3. Expression of -adrenergic receptors in adipose tissue of AHNAK 
KO mice. 
Relative mRNA levels of the Adrb3 (A), Adrb1(B), Adrb2 (C), and Rgs2 (D), 
assessed by qRT-PCR in CL treated adipose tissue (n = 5); the expression was 
normalized to 36B4. Values were normalized to 36B4. The data are presented as 
the means ± SEM; *P < 0.05, **P < 0.01, ***P < 0.001, wild-type (WT) versus 
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Figure 3-4. Lipolysis signaling pathway in WAT of AHNAK KO mice by -
adrenergic signals. 
Levels of phosphorylated HSL and PKA substrates assessed by immunoblotting in 
eWAT (A) and iWAT (B); GAPDH was used as a loading control. The data are 
presented as the means ± SEM; *P < 0.05, **P < 0.01, ***P < 0.001, wild-type 
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Figure 3-5. Lipolysis signaling pathway in BAT of AHNAK KO mice by -
adrenergic signals 
Levels of phosphorylated HSL and PKA substrates assessed by immunoblotting in 
BAT; GAPDH was used as a loading control. The data are presented as the means ± 
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Figure 3-6. Enhanced -adrenergic signaling in WAT of AHNAK KO mice fed 
a HFD.  
CL-316243 stimulated glycerol (A) and FFA (B) levels in serum from HFD fed 
mice (20 min after CL injection)(n=4-5). The data are presented as the means ± 
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3.3.2. AHNAK negatively regulated -adrenergic signaling 
in adipocytes 
  
Mice lacking AHNAK exhibited enhanced -adrenergic signaling in WAT; 
therefore, we examined the effect of AHNAK on acute adrenergic signaling 
in murine adipose tissue and adipocytes. For this, isolated adipose tissues 
were incubated with CL for 2h at 37°C and the release of FFA and glycerol 
to media was determined and normalized to fat tissue weight. In both eWAT 
and iWAT of AHNAK-deficient mice under either RC or HFD feeding, CL 
treatment led to significantly increased lipolysis, as indicated by FFA and 
free glycerol release. (Figure 3-7A-D). Taken together, these results suggest 
that fat increased lipolysis in AHNAK ablation is mediated by 3-adrenergic 
signaling through induction of Adrb3.  
 Next, we employed 3T3-L1 cell to evaluate the role of Ahnak in 
adrenergic signaling in vitro. The amount of released FFA and free glycerol 
were remarkably elevated in Ahnak knock-down cells (Figure 3-8A-C). In 
consistent with increased lipolysis on adrenergic signaling, the levels of 
phosphorylated HSL and PKA substrates were increased in Ahnak knock-
down cell after CL treatment (Figure 3-8D). Taken together, these results 
suggest that Ahnak is implicated in regulation of -adrenergic signaling in 
adipocytes.  
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Figure 3-7. Ex vivo lipolysis in response to -adrenergic stimulation from 
AHNAK KO mice. 
(A–D) Explants from RC-fed eWAT (A), iWAT (B), HFD fed eWAT (C) and HFD-
fed iWAT (D) were treated or not with CL-316243 for 2 h at 37°C and analyzed for 
the release of glycerol and FFA (n=4-6 per group). The values were normalized to 
the wet weight of the explants. The data are presented as the means ± SEM; *P < 
0.05, **P < 0.01, ***P < 0.001, wild-type (WT) versus Ahnak-/- (KO) mice. 
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Figure 3-8. AHNAK deficiency enhanced lipolysis in adipocytes in vitro in 
response to -adrenergic stimulation .  
(A) 3T3-L1 adipocytes were transfected with Ahnak-specific or control siRNA, 
stimulated with CL-316243 for 3 h, and analyzed for FFA (B) and glycerol (C) 
release, and Ahnak mRNA levels by qPCR. (D) The expression of phosphorylated 
HSL and PKA substrates analyzed by immunoblotting. siC, siControl; siA, 
siAHNAK. The data are presented as the ± SEM, *P < 0.05, **P < 0.01, ***P < 
0.001, wild-type (WT) versus Ahnak-/- (KO) mice.
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3.3.3. Lipolytic action via NPs in AHNAK KO mice 
Increases in sympathetic activity by 3 adrenergic stimulation led to 
activation of lipolytic mechanisms of AHNAK deficient WAT. Given the 
parallel nature of β-AR and NP signaling and responses, we next 
investigated whether changes in the NP system were stimulated by CL 
exposure. As shown in Figure 38, AHNAK KO mice injected by CL had 
significantly increased levels of ANP, BNP, and CNP in eWAT (Figure 3-
9A). Concomitantly, in eWAT, the ratio of gene expression of NPR-A to 
NPR-C was also increased in CL treated AHNAK KO mice, because 
elevation of NPRA mRNA levels was accompanied by a decrease in NPR-C 
levels in AHNAK deficient eWAT (Figure 3-9B). However, there were no 
differences in BAT between WT and KO mice (Figure 3-10). Furthermore, 
expression levels of NPs were elevated with a contemporaneous decrease in 
NPR-C levels in the fasting state in AHNAK KO mice (Figure 3-11). 
Interestingly, cardiac expression of NPs was not altered in the fasting 
condition between WT and KO mice (Figure 3-12). Therefore, these 
changes in eWAT suggest that the NP system may function together with the 
activation of -AR and enhance fat lipolysis in AHNAK KO mice 
 





Figure 3-9. AHNAK deficiency enhanced NPs expression in eWAT in response 
to -adrenergic stimulation.  
(A) mRNA levels of NPs and NP receptors in eWAT (n=5-7). (B) Ratio of NPR-A 
to NPR-C in eWAT. The data are presented as the ± SEM, *P < 0.05, **P < 0.01, 
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Figure 3-10. AHNAK deficiency enhanced NPs expression in BAT in response 
to -adrenergic stimulation.  
mRNA levels of NPs and NP receptors in BAT (n=5-7). The data are presented as 
the ± SEM, *P < 0.05, **P < 0.01, ***P < 0.001, wild-type (WT) versus Ahnak-/- 
(KO) mice. 
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Figure 3-11. AHNAK deficiency enhanced NPs expression in eWAT during 
fasting condition 
The data are presented as the ± SEM (n=5), *P < 0.05, **P < 0.01, ***P < 0.001, 
wild-type (WT) versus Ahnak-/- (KO) mice. 
  
` - 98 -
 
Figure 3-12. NPs expression in heart 
The data are presented as the ± SEM (n=5), *P < 0.05, **P < 0.01, ***P < 0.001, 
wild-type (WT) versus Ahnak-/- (KO) mice. 
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3.4. DISCUSSION 
 
 ADRB3 activation stimulates cAMP and PKA activation, which 
promotes adipocyte lipolysis via HSL phosphorylation (Deiuliis et al., 2010). 
In this study, AHNAK-deficient CL-316243-stimulated mice demonstrated 
PKA activation in WAT, which was accompanied by increased 
phosphorylation of HSL and FFA mobilization, indicating enhanced 
lipolysis. Moreover, AHNAK genetic ablation increased expression levels of 
the genes involved in fat browning (Ucp1, Pgc1a, and Cpt2) and 
mitochondrial oxidative phosphorylation in response to -adrenergic 
signaling. Our results suggest that AHNAK deficiency may contribute to 
improved catecholamine sensitivity by enhancing ADRB3 expression and 
signaling in WAT.  
 NPs, on the other hand, increases cGMP, and subsequently activates 
cGMP-dependent protein kinase leading to lipolysis (Potter and Hunter, 
2001; Sengenès et al., 2003). Since NPs system via PKG appeared to share a 
common mechanism to increase lipolysis with β-agonists through PKA 
(Lafontan et al., 2008). The lipolytic effect of NPs may be determined by 
the ratio of NPR-A to the clearance receptor NPR-C in adipocytes (Moro 
and Lafontan, 2013; Sengenès et al., 2002).In ealier work, NPs promote 
browning of WAT to increase energy expenditure (Bordicchia et al., 2012). 
Here we show that AHNAK null mice promoted lipolysis via enhanced 
responsiveness to 3-adrenergic signals, accompanied by the elevated levels 
of NPs system and the ratio of NPRA to NPR-C expression. Although it still 
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remains to be determined the role of AHNAK in WAT, possible candidate 
sites are proposed; recruitment of eosinophil, regulation of 3-AR, NPR-A 
and NPR-C activity(Figure 3-13). We suggest that AHNAK could regulate 
thermogenesis and lipolysis through those potential mechanisms.  
 





Figure 3-13. Putative model for parallel activation of 3-AR and NPs in 
AHNAK deficient WAT 
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Table 1. Sequences of primers used for real-time PCR 
Gene Sequence Gene Sequence 




Acrp30 GGCAGGAAAGGAGAACCTGG Dio2 CAGTGTGGTGCACGTCTCCAATC 
AGCCTTGTCCTTCTTGAAGAG TGAACCAAAGTTGACCACCAG 
Adrb1 CTCATCGTGGTGGGTAACGTG Glut4 AAAAGTGCCTGAAACCAGAG 
ACACACAGCACATCTACCGAA TCACCTCCTGCTCTAAAAGG 
Adrb2 GGGAACGACAGCGACTTCTT HSL GGAGCACTACAAACGCAAC 
GCCAGGACGATAACCGACAT TCCCGTAGGTCATAGGAGAT 
Adrb3 ATTGGCGCTGACTGGCCATT IL-4 GGTCTCAACCCCCAGCTAGT 
GCCGTGTTAAGGAATCTGCTG GCCGATGATCTCTCTCAAGTGAT 
Ahnak TGTCACTGGCTCACCTGAAG IL-4R GTCACAGAGCAGCCTTCACA 
CTTGCCTTTAGCGTCTCCAC AAAACTCCGGTAGGCAGGAT 
Anp CCTGTGTACAGTGCGGTGTC IL-13 CCTGGCTCTTGCTTGCCTT 
CCTAGAAGCACTGCCGTCTC GGTCTTGTGTGATGTTGCTCA 
aP2 TTCGATGAAATCACCGCAGA LPL TCTGTACGGCACAGTGG 
AGGGCCCCGCCATCT CCTCTCGATGACGAAGC 
Bnp CTGAAGGTGCTGTCCCAGAT NPR-A AGTACGCCAACAACCTGGAG 
GTTCTTTTGTGAGGCCTTG AAGAGCTGTAAAGCCCACGA 
Ccr3 TCGAGCCCGAACTGTGACT NPR-B TCATGACAGCCCATGGTAA 
CCTCTGGATAGCGAGGACTG GGTGACAATGCAGATGTTGG 





 AAATGTCTTCACTTTAATGCTC GAA  
TGCTGCTGTTCCTGTTTTC 
C/EBPδ  TTCCAACCCCTTCCCTGAT Ppar TCGGCGAACTATTCGGCTG 
 CTGGAGGGTTTGTGTTTTCTGT  GCACTTGTGAAAACGGCAGT 
Cidea TGCTCTTCTGTATCGCCCAGT Pparβ/δ TTGAGCCCAAGTTCGAGTTTG 
 GCCGTGTTAAGGAATCTGCTG  CGGTCTCCACACAGAATGATG 
Cnp AGCCAATCTCAAGGGAGACC Prdm16 CAGCACGGTGAAGCCATTC 
 TAACATCCCAGACCGCTCAT  GCGTGCATCCGCTTGTG 
Cox8b GAACCATGAAGCCAACGACT Rgs2 GAGAAAATGAAGCGGACACTCT 
 GCGAAGTTCACAGTGGTTCC  GCAGCCAGCCCATATTTACTG 
Cpt1 TCTATGAGGGCTCGCG Siglec-F CTGGCTACGGACGGTTATTCG 
 CGTCAGGGTTGTAGCA  GGAATTGGGGTACTGGACTTG 
Cpt2 GCCCAGCTTCCATCTTTACT Ucp1 ACTGCCACACCTCCAGTCATT 
 CAGGATGTTGTGGTTTATCCGC  CTTTGGCTCACTCAGGATTGG 
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The results of this study demonstrated that AHNAK promotes adipose tissue 
development and obesity by potentiating BMP4/SMAD1 signaling and that 
AHNAK can serve as a novel regulator of metabolic homeostasis. Our data 
thus expand the current knowledge regarding the early determination of 
adipose tissue development and highlight a potential indication for treating 
obesity-associated metabolic disorders. Moreover, enhanced response to β-
adrenergic signaling in AHNAK KO mice induces to the development of 
beige fat, which promotes thermogenic effects with minimal alteration in 
BAT activity and mass. AHNAK null mice also promoted lipolysis via 
enhanced responsiveness to3-adrenergic signals, accompanied by the 
elevated levels of NPs system and the ratio of NPRA to NPR-C expression. 
Enhanced adrenergic and NPs signaling could increase thermogenic 
ability and lipolytic activity in AHNAK KO mice. Although the precise 
molecular mechanism underlying AHNAK involvement in -adrenergic 
signaling remains to be determined, the downregulation of AHNAK levels 
can be a new approach to increase energy metabolism in response to -
adrenergic stimulation and NPs signals in adipose tissue, suggesting a 
promising strategy to treat obesity.  
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 AHNAK 단백질은 약 700kDa에 이르는 거대한 크기의 인
산화단백질(phosphoprotein)로서, 세포부착(cell adhesion), 세포
증식(Proliferation), 칼슘신호전달 등에서 중요한 역할을 한다. 최
근에 AHNAK 발현이 비만상태에서 변화한다는 새로운 증거들이 
밝혀지고 있다. 그럼에도 불구하고, 지방조직 발생과정에서 
AHNAK의 역할은 잘 알려져 있지 않다. 이번 연구에서 지방세포
분화와 포도당 항상성 (glucose homeostasis) 에 있어서 
AHNAK의 분자적 기전을 밝여내고자 한다. AHNAK 유전자 결손 
마우스는 고지방식이에 의한 비만발생에 저항성을 갖고 이는 지방
축적의 감소에 기인한다. 지방세포분화는 체내의 지방 축적에 영
향을 미치는데, AHNAK 유전자 결손 마우스의 지방유래중간엽줄
기세포 (adipose derived mesenchymal stem cells)을 이용한 지
방세포로의 분화능이 감소해 있었다. 또한 AHNAK의 결핍은 
BMP4/SMAD1 신호전달의 감소로 이어졌고, 그 결과 지방세포분
화와 관련한 주요조절인자들의 발현이 감소하였다. AHNAK은 
SMAD1과 상호작용하여 PPAR2의 전사활성에 영향을 미친다. 
동시에, 고지방식이를 먹인 AHNAK 결손 마우스는 대조군에 비
해 에너지 섭취나 활동량에는 변화가 없이 포도당 내성(glucose 
tolerace), 인슐린 민감도(insulin sensitivity)가 개선되고 그리고 
에너지 소비가 증가하는 등 대사지표가 향상되었다. 따라서 본 연
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구 결과로 미루어 볼 때 AHNAK은 SMAD1 단백질과의 상호작용
을 통해 지방조직발달을 조절하여 체내 지방축적에 중요한 역할을 
하며 대사항상성에도 관여되어 있다고 생각한다. 
 이와 더불어 열생성을 통한 갈색지방의 활성과 에너지 소
비의 변화는 는 비만에 대한 치료타겟으로 전도유망하다고 생각된
다. 지방조직에서 베타3 특이적인 아드레너직 수용체 작용물질(3 
specific adrenergic receptor agonist)은 지방분해와 지방 산화 
뿐만 아니라, 열생성에도 관련되어 있다. 고지방 식이를 먹인 마우
스의 백색 지방 조직에서 AHNAK 유전자 결핍시에 열발생이 증
가하였고, 이 결과는 베이지 지방이 발달하여 에너지 소비가 향상
된 것을 예상할 수 있다. 본 연구에서 AHNAK 결손 마우스에 
CL-316243을 주사하였을 때 백색지방에서는 갈색지방화와 열발
생 관련 유전자의 발현을 증가시켰지만 갈색지방에서는 변화가 없
었다. 동시에 AHNAK 결손 마우스에서는 CL-316243에 반응한 
백색지방에서 미토콘드리아 생합성 증가를 수반하는 에너지 소비
가 증가하였다. CL-316243은 AHNAK 결손 마우스에서 대조군
과 비교하여 PKA 신호전달을 활성화시켜 HSL의 인산화를 증가
시켰고, 지방분해를 증가시켜 글리세롤이 분비가 증가하였다. 
AHNAK 유전자가 결손된 지방조직은 대조군에 비해 호산구
(eosinophil)과 2형 사이토카인 (type2 cytokine)인 IL-4/IL-
13의 양이 증가해있었고, 이는 CL-316243에 반응하여 백색지방
의 갈색지방화와 미토콘드리아의 생합성을 향상시킨 것으로 생각
된다. 이것은 AHNAK 결손 마우스의 백색지방에서 Adrb3유전자
와 tyrosine hydroxylase 유전자의 발현증가로 인한 교감신경 활
성도가 증가한 것과 관련이 있다. 따라서 본 연구 결과는 
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AHNAK 유전자가 베타 아드레너직 신호를 통해 백색지방에서의 
열발생과 지방분해를 조절하는데 중요한 역할을 한다는 것을 보여
준다. 
Keywords: Ahnak, adipogenesis, BMP4/SMAD1, obesity, browning, 
lipolysis, thermogenesis, β-adrenergic signaling 
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